Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced the completion of its new laboratory located in Bogota, Colombia. Specializing in the manufacturing of compound formulations…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is grabbing attention in the competitive electric vehicle space. A leading investor resource covering EV stocks, Investor Ideas recently released a special news report about the…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has announced it will release financial numbers for its third quarter 2022 on Nov. 21, 2022, after market close. The company also plans…
EverGen commenced construction at its Core RNG Expansion Project at Fraser Valley Biogas; project is advancing on schedule and on budget with expected completion in Q1 2023 Expansion is estimated to double FVB’s capacity to…
CNS Pharmaceuticals CEO John Climaco participated in 5K run on November 5, to show support for brain tumor patients worldwide and help raise funds for research The company recently announced European clinical trial site activations…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has successfully completed the third stop of the Mullen FIVE Strikingly Different EV Crossover Tour in Las Vegas, Nevada. According to…
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases, today announced financial results for the third quarter ended Sept. 30, 2022, and…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), has reported unaudited financial results for its second quarter ended Sept. 30, 2022, as well as recent business highlights. “We…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced its Q3 2022 financial report; the company…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an over-the-road (“OTR”) shipping technology investor based in Houston, Texas. The company is focused on further improving commerce between the United States and Mexico by developing solutions that make…
In 2021, a third of the world’s assets under management, including the money of growing numbers of huge public pension funds, were invested according to ESG principles, with the year posting the highest expenditure on…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), continues to sign contracts and agreements as it delivers on its mission to provide safety and security to a growing number of organizations around…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements (“REE”), today announced its entry into a definitive agreement to sell three wholly owned subsidiaries that together hold…
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, has announced financial results for the third quarter ended Sept. 30, 2022, and year-to-date ended Sept.…
Tingo (OTC: TMNA) today announced that it has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three and nine months ended Sept. 30, 2022. Among the highlights,…
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is working with the 357 Company to launch 357’s Canna Logistics division. The new division is an expansion beyond…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report…
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, appears to have a strong position to expedite growth as it remains committed to delivering on…